CLINICS

ISSN-1807-5932
CLINICS
CONTENTS
Clinics 2011 66(S1):1–77
EDITORIAL
Clinics Reviews
Mauricio Rocha e Silva . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .1
Long-term potentiation and long-term depression: a clinical perspective
Timothy V. P. Bliss, Sam F. Cooke . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .3
Neuroimaging in Alzheimer’s disease: current role in clinical practice and potential future applications
Luiz Kobuti Ferreira, Geraldo F. Busatto . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19
Future developments in brain-machine interface research
Mikhail A. Lebedev, Andrew J. Tate, Timothy L. Hanson, Zheng Li, Joseph E. O’Doherty, Jesse A. Winans, Peter J. Ifft,
Katie Z. Zhuang, Nathan A. Fitzsimmons, David A. Schwarz, Andrew M. Fuller, Je Hi An, Miguel A. L. Nicolelis . . 25
Metabolism and Brain Cancer
Suely Kazue Nagahashi Marie, Sueli Mieko Oba Shinjo . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33
Insights into Alzheimer disease pathogenesis from studies in transgenic animal models
Evelin L. Schaeffer, Micheli Figueiró, Wagner F. Gattaz . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 45
Animal models of intellectual disability: towards a translational approach
Carla A. Scorza, Esper A. Cavalheiro . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 55
Sudden unexpected death in epilepsy: an important concern
Fulvio Alexandre Scorza, Roberta Monterazzo Cysneiros, Marly de Albuquerque, Marcello Scattolini,
Ricardo Mario Arida . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 65
The role of the cerebellum in schizophrenia: from cognition to molecular pathways
Peyman Yeganeh-Doost, Oliver Gruber, Peter Falkai, Andrea Schmitt . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 71